We are live on ! Find out more
BFT.WS

Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class
BFT.WS

Delisted

BFT.WS was delisted on the 30th of March, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 50 → 0 (-50)

100% less capital invested

Capital invested by funds: $74M → $0 (-$74M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 50

Holders
–
Holders Change
-50
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
50
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
-$14.6M
2
TP
Third Point
New York
-$7.65M
3
MF
Magnetar Financial
Illinois
-$5.32M
4
CCM
CAAS Capital Management
New York
-$4.59M
5
RCM
Ratan Capital Management
Florida
-$4.46M

BFT.WS Hedge Fund Activity: Q1 2021 in Review

0 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class (BFT.WS) for Q1 2021, worth a combined $0 — down 100% from $74M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of BFT.WS and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Empyrean Capital Partners, exiting entirely with an estimated $14.6M sold.

  • 0 institutional investors held Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class (BFT.WS) as of Q1 2021, down from 50 in Q4 2020.
  • Funds reported $0 of Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class positions in Q1 2021 and 50 closed out, a net change of -50 holders.
  • The largest Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class seller in Q1 2021 was Empyrean Capital Partners, an estimated $14.6M sold.

Based on aggregated 13F filings for Q1 2021.